19th Annual Thomas J. Fogarty Lecture: Focus on Innovation featuring Jessica Mega, MD, MPH, Chief Medical Officer of Verily
Nov 3 @ 4:00 pm – 5:00 pm
From the Innovator’s Workbench
Feb 13 @ 5:30 pm – 7:00 pm

Stanford Biodesign launched the From the Innovator’s Workbench speaker’s series in 2003 to enable the Stanford Biodesign community and the public to learn from the greatest health technology innovators of our time. With multiple Innovator’s Workbench events held annually, each one features an individual or a panel of innovators being interviewed about their innovation process, insights, and perspectives on the changing healthcare landscape.

This event will feature a panel consisting of Josh Makower, MD and the ExploraMed team. David Cassak, a renowned healthcare journalist, is the moderator of the event.

20th Annual Fogarty Lecture
Oct 26 @ 4:00 pm – 5:00 pm
Innovator’s Workbench: Jason Field
Apr 3 @ 5:30 pm

Stanford Byers Center for Biodesign
From the Innovator’s Workbench: 
Jason Field, President & CEO
W.L. Gore & Associates, Inc.

Register here:

2019 Fogarty Lecture
Oct 11 @ 4:00 pm – 5:00 pm

21st Annual Thomas J. Fogarty Lecture: Focus on Innovation featuring Brook Byers, Founding Partner, Kleiner Perkins

The Fogarty lectureship was established to bring together a diverse community in Silicon Valley focusing on leaders in discovery, invention, innovation, and entrepreneurship. This event is sponsored by the Stanford Byers Center for Biodesign, Fogarty Institute for Innovation and the Stanford Department of Surgery.

About Brook Byers:
Brook Byers is a founding member of Kleiner Perkins. A venture capital investor since 1972, Brook has been closely involved with more than 60 new technology-based ventures, many of which have become public companies. He formed the first life sciences practice group in the venture capital profession in 1984 and led KP to become a premier venture capital firm in the medical, healthcare and biotechnology sectors. KP has invested in and helped build more than 120 life sciences companies that have developed hundreds of products to treat underserved medical needs for many millions of patients. Brook has been an innovator in precision medicine and health genomics, antibodies and devices. He was the founding president and then chairman of four biotechnology companies that were incubated in KP’s offices and went on to become public companies with an aggregate market value of more than US $8 billion. He serves on the board of directors of Epiodyne, Enjoy, Newsela, Octave and Verana Health.

Brook serves on the Board of Overseers of the University of California San Francisco medical campus and hospitals, the Stanford Medicine Advisory Council, the Board of Directors of the New Schools Foundation, the Advisory Board of Stanford’s Center for Precision Health and Integrated Diagnostics and the Stanford Center for Biodesign. In 2007, UCSF awarded Brook the UCSF Medal, its honorary degree equivalent. In 2008, Brook was elected a fellow of the American Academy of Arts and Sciences. In 2009, he received the Lifetime Achievement Award from the National Venture Capital Association. In 2010, he received an honorary Ph.D. from Georgia Institute of Technology.

Raised in Atlanta, Georgia, Brook graduated with a bachelor’s degree in electrical engineering from Georgia Tech and received an M.B.A. from Stanford University.